Lb Pharmaceuticals INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
Deep Track Capital and its affiliates have increased their beneficial ownership in LB Pharmaceuticals Inc to 11.7% following a private placement of common stock and pre-funded warrants.
NASDAQ
Investment group Pontifax, through its various entities and managing partners, has disclosed a 6.3% beneficial ownership stake in LB Pharmaceuticals Inc. following the company's IPO.
NASDAQ
Deep Track Capital and its affiliated funds have collectively acquired a 14.9% beneficial ownership stake in LB Pharmaceuticals Inc. following its IPO.